O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+15.9%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.71B
AUM Growth
+$6.71B
(+24%)
Cap. Flow
+$780M
Cap. Flow
% of AUM
11.63%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
137
New
19
Increased
49
Reduced
25
Closed
20
Top Buys
| 1 |
RLYP
RELYPSA INC COM
RLYP
|
$249M |
| 2 |
Perrigo
PRGO
|
$119M |
| 3 |
AbbVie
ABBV
|
$107M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$83.9M |
| 5 |
CELG
Celgene Corp
CELG
|
$76.1M |
Top Sells
| 1 |
Merck
MRK
|
$177M |
| 2 |
Elevance Health
ELV
|
$71.8M |
| 3 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
$56.2M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$56.1M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$50.4M |
Sector Composition
| 1 | Healthcare | 84.81% |
| 2 | Financials | 1.2% |
| 3 | Technology | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
51
DELISTED
NxStage Medical Inc.
NXTM
| $26.8M | 0.39% |
2,679,216
-435,284
| -14% | -$4.35M |
|
|
ARRY
52
DELISTED
Array Biopharma Inc
ARRY
| $26.7M | 0.39% |
5,325,000
+493,400
| +10% | +$2.47M |
|
|
XNPT
53
DELISTED
XENOPORT, INC.
XNPT
| $26.4M | 0.39% |
4,590,800
+368,200
| +9% | +$2.12M |
|
|
PTLA
54
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $24.7M | 0.36% |
957,700
+630,700
| +193% | +$16.2M |
|
55
Neurocrine Biosciences
NBIX
$13.5B
| $24.6M | 0.36% |
2,631,000
+2,056,000
| +358% | +$19.2M |
|
56
Arrowhead Research
ARWR
$3.84B
| $23.1M | 0.34% |
+2,128,900
| New | +$23.1M |
|
|
DRTX
57
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $22.8M | 0.34% |
1,785,714
| – | – |
|
58
Cerus
CERS
$251M
| $21.8M | 0.32% |
3,375,000
+817,100
| +32% | +$5.27M |
|
|
MRTX
59
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21.2M | 0.31% |
1,274,332
+125,000
| +11% | +$2.08M |
|
|
ATRS
60
DELISTED
Antares Pharma, Inc.
ATRS
| $20.5M | 0.3% |
4,592,000
+227,000
| +5% | +$1.01M |
|
61
Xoma
XOMA
$421M
| $19M | 0.28% |
2,829,627
+42,557
| +2% | +$286K |
|
62
Vertex Pharmaceuticals
VRTX
$102B
| $18.9M | 0.28% |
255,000
-83,000
| -25% | -$6.17M |
|
63
Medtronic
MDT
$118B
| $18.5M | 0.27% |
323,000
-87,000
| -21% | -$4.99M |
|
64
Bausch Health
BHC
$2.72B
| $18.4M | 0.27% |
157,000
+19,000
| +14% | +$2.23M |
|
65
Baxter International
BAX
$12.1B
| $17M | 0.25% |
244,000
+81,200
| +50% | +$5.65M |
|
66
MEI Pharma
MEIP
$149M
| $15.9M | 0.23% |
+1,989,500
| New | +$15.9M |
|
67
Cardinal Health
CAH
$36B
| $15.4M | 0.23% |
230,300
+41,000
| +22% | +$2.74M |
|
68
Jazz Pharmaceuticals
JAZZ
$7.99B
| $14.6M | 0.21% |
115,000
+43,000
| +60% | +$5.44M |
|
|
AMBI
69
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $14.4M | 0.21% |
1,490,769
| – | – |
|
70
MacroGenics
MGNX
$121M
| $13.5M | 0.2% |
+491,897
| New | +$13.5M |
|
|
GWPH
71
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $13.3M | 0.2% |
+320,200
| New | +$13.3M |
|
72
Vanda Pharmaceuticals
VNDA
$279M
| $12.3M | 0.18% |
+990,000
| New | +$12.3M |
|
|
ARQL
73
DELISTED
Arqule Inc
ARQL
| $12.3M | 0.18% |
5,702,000
+1,336,000
| +31% | +$2.87M |
|
74
Abbott
ABT
$230B
| $11.7M | 0.17% |
305,000
-95,000
| -24% | -$3.64M |
|
|
MRGE
75
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $10.7M | 0.16% |
4,628,500
+332,500
| +8% | +$771K |
|